FGF23 and chronic kidney disease: Furthermore, Agoro et al. reported that inhibiting FGF-23 signaling rescues anemia and iron deficiency in a mice model of CKD by normalizing the hemoglobin levels, decreasing erythroid cell apoptosis, and increasing serum erythropoietin, iron, and ferritin.